top of page

Granted over 7 Million Federal Funding

image (1)_edited.png

 In Vitro Diagnostic Solutions has successfully secured and executed over $7 million in federal funding from the National Institutes of Health and the National Science Foundation. Through these programs, we have successfully demonstrated strong scientific feasibility and launched commercialization of several innovative chemistries in a universal platform that will transform the market and increase accessibility for point of care diagnostics across a wide spectrum of challenge diseases.

Periodic Table

GRANTS RECEIVED

Diagnosis and monitoring of Glucose-6-Phosphate Dehydrogenase (G6PD)

Grant Number: 2SB1AI129057-04
Grant Agency and Type: NIH NIAID
Amount: $ 2,893,164
Principal Investigator: Robert Harper
Disease Indication: G6PD

Glucose-6-Phosphate Dehydrogenase 

(Phase I SBIR)

Grant Number: 1R43AI129057-01A1
Grant Agency and Type: NIH NIAID, Phase I SBIR
Amount: $191,220
Principal Investigator: Robert Harper
Disease Indication: Malaria

Phenylalanine Determination (Phase I SBIR)

Grant Number: 1R43GM126593-01A1
Grant Agency and Type: NIH NIGMS, Phase I SBIR
Amount: $224,700
Principal Investigator: Robert Harper
Disease Indication: Phenylketonuria

Determination of the Bilirubin (Phase I SBIR)

Grant Number: 1R43HD095727-01
Grant Agency and Type: NIH NICHD, Phase I SBIR
Amount: $224,700
Principal Investigator: Robert Harper
Disease Indication: Kernicterus

Umbel Microchip, a microfluidic based blood analyzer

Grant Agency:  New Jersey Department of Labor and Workforce Development
Grant Type: Innovation and Research Fellowship Program (IRFP)
Amount: $115,000
Principal Investigators: Robert Harper & Shima Dalirirad
Disease Indication: Blood Analyzer

Glucose-6-Phosphate Dehydrogenase

(Phase II SBIR)

Grant Number: 2R44AI129057-02A1
Grant Agency and Type: NIH NIAID, Phase II SBIR
Amount: $1,447,330
Principal Investigator: Robert Harper
Disease Indication: Malaria

Phenylalanine Determination (Phase II SBIR)

Grant Number: 2 R44 GM126593-02A1
Grant Agency and Type: NIH NIGMS, Phase II SBIR
Amount: $1,946,957
Principal Investigator: Robert Harper
Disease Indication: Phenylketonuria

Simultaneous G6PD and Hemoglobin (Phase I SBIR)

Grant Number:1746309
Grant Agency and Type: National Science Foundation, Phase I SBIR
Amount: $225,000
Principal Investigator: Robert Harper
Disease Indication: Malaria

bottom of page